Bionano Genomics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	36.12	27.8	17.98	8.5	10.13	12	9.51	6.79
Revenue Growth (YoY)	29.90%	54.62%	111.47%	-16.06%	-15.59%	26.26%	39.93%	-
Cost of Revenue	26.55	21.86	14.11	5.73	6.77	8.71	6.03	3.58
Gross Profit	9.57	5.95	3.87	2.77	3.36	3.29	3.47	3.21
Selling, General & Admin	93.5	88.6	58.49	31.07	20.16	14.22	14.08	12.95
Research & Development	54.03	49.05	22.49	10.26	9.08	9.48	12.01	11.43
Other Operating Expenses	73.83	0.22	0.06	0.01	0	0	0.6	0
Operating Expenses	221.36	137.87	81.03	41.33	29.24	23.7	26.69	24.38
Operating Income	-211.8	-131.92	-77.16	-38.56	-25.87	-20.42	-23.22	-21.17
Interest Expense / Income	5.12	0.3	0.93	2.52	2.29	1.38	0.59	0.47
Other Expense / Income	15.52	-1.51	0.07	-	1.63	-3.32	-0.46	-2.8
Pretax Income	-232.43	-130.71	-78.15	-41.08	-29.79	-18.48	-23.35	-18.84
Income Tax	0.06	1.88	-5.72	0.03	0.02	0.02	0.02	0.01
Net Income	-232.49	-132.6	-72.44	-41.11	-29.82	-18.5	-23.37	-18.85
Shares Outstanding (Basic)	34	29	28	10	1	1	0	0
Shares Outstanding (Diluted)	34	29	28	10	1	1	0	0
Shares Change	18.08%	4.49%	165.50%	596.03%	111.64%	162.01%	18.17%	-
EPS (Basic)	-6.81	-4.58	-2.60	-3.90	-19.90	-26.10	-86.50	-82.46
EPS (Diluted)	-6.81	-4.58	-2.60	-3.90	-19.90	-26.10	-86.50	-82.46
Free Cash Flow	-126.87	-127.99	-73.99	-38.31	-29.59	-20.28	-21.84	-24.85
Free Cash Flow Per Share	-3.71	-4.43	-2.67	-3.67	-19.76	-28.65	-80.84	-108.70
Gross Margin	26.49%	21.38%	21.54%	32.61%	33.18%	27.41%	36.55%	47.32%
Operating Margin	-586.43%	-474.50%	-429.12%	-453.46%	-255.44%	-170.12%	-244.28%	-311.63%
Profit Margin	-643.74%	-476.93%	-402.84%	-483.43%	-294.34%	-154.13%	-245.82%	-277.48%
Free Cash Flow Margin	-351.29%	-460.36%	-411.51%	-450.59%	-292.12%	-168.95%	-229.73%	-365.77%
EBITDA	-213.34	-120.1	-73.18	-37.08	-26.38	-15.78	-21.25	-17.25
EBITDA Margin	-590.72%	-431.97%	-407.01%	-436.07%	-260.43%	-131.49%	-223.58%	-253.95%
Depreciation & Amortization	13.97	10.32	4.04	1.48	1.13	1.32	1.5	1.12
EBIT	-227.31	-130.41	-77.23	-38.56	-27.51	-17.1	-22.76	-18.37
EBIT Margin	-629.39%	-469.08%	-429.48%	-453.46%	-271.56%	-142.49%	-239.41%	-270.37%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).